Renan biopsy in high-risk patients with medical diseases of the kidney

Kevin P. Stiles, Christina M. Yuan, Ellen M. Chung, Robert D. Lyon, J. David Lane, Kevin C. Abbott*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The number of high-risk patients undergoing renal biopsy is likely to increase in the near future because of the increased use of anticoagulants for such conditions as atrial fibrillation, combined liver and kidney disease caused by hepatitis C, and the aging of the population. Nephrologists need to become increasingly familiar with evaluating such patients through both specialized management of percutaneous kidney biopsy and alternate methods of renal biopsy, which primarily consist of open (surgical) biopsy, transjugular (transvenous) biopsy, and laparoscopic biopsy. The indications, complications, and general approach to such patients are discussed. This is a US government work. There are no restrictions on its use.

Original languageEnglish
Pages (from-to)419-433
Number of pages15
JournalAmerican Journal of Kidney Diseases
Volume36
Issue number2
DOIs
StatePublished - Aug 2000
Externally publishedYes

Keywords

  • Coagulopathy
  • High risk
  • Kidney biopsy
  • Laparoscopic
  • Open
  • Renal biopsy
  • Transjugular
  • Transvenous
  • Uremia

Fingerprint

Dive into the research topics of 'Renan biopsy in high-risk patients with medical diseases of the kidney'. Together they form a unique fingerprint.

Cite this